Picture of United Laboratories International Holdings logo

3933 United Laboratories International Holdings Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapSuper Stock

Annual income statement for United Laboratories International Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8,3938,7729,70311,33413,740
Cost of Revenue
Gross Profit3,6213,8064,2114,9696,335
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses7,2707,7098,4419,24610,329
Operating Profit1,1221,0641,2632,0893,411
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes8428821,2032,0073,344
Provision for Income Taxes
Net Income After Taxes6427019901,5812,701
Minority Interest
Net Income Before Extraordinary Items
Net Income6427039881,5812,701
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income6427039881,5812,701
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3020.3780.5470.9061.51
Dividends per Share
Special Dividends per Share